CMN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This valuation method assumes that the stock valuation will revert to its historical mean in terms of Price/Sales Ratio. The reason we use P/S Ratio instead of P/E Ratio or P/B Ratio is because Price/Sales Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median P/S Value is calculated as trailing twelve months (TTM) revenue per share times 10-Year median P/S ratio. Cantel Medical Corp's revenue per share for the trailing twelve months (TTM) ended in Jan. 2016 was $14.646. Cantel Medical Corp's 10-Year median P/S ratio is 1.50. Therefore, the Median P/S Value for today is $21.97.
As of today, Cantel Medical Corp's share price is $66.99. Cantel Medical Corp's median P/S value is $21.97. Therefore, Cantel Medical Corp's Price to Median P/S Value Ratio for today is 3.05.
During the past 13 years, the highest Price to Median P/S Value Ratio of Cantel Medical Corp was 2.80. The lowest was 0.27. And the median was 0.81.
Cantel Medical Corp's Median P/S Value for today is calculated as
|Median P/S Value||=||Total Annual Sales / Shares Outstanding||*||10-Year Median P/S Ratio|
|=||Revenue per Share (TTM)||*||10-Year Median P/S Ratio|
10-Year Median P/S Ratio is 1.50.
Cantel Medical Corp's revenue per share for the trailing twelve months (TTM) ended in Jan. 2016 was 3.431 (Apr. 2015 ) + 3.671 (Jul. 2015 ) + 3.721 (Oct. 2015 ) + 3.823 (Jan. 2016 ) = $14.646.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the companys value.
Cantel Medical Corp's Price to Median P/S Value Ratio for today is calculated as
|Price to Median P/S Value||=||Share Price||/||Median P/S Value|
Cantel Medical Corp Annual Data
Cantel Medical Corp Quarterly Data